KRIYA METABOLIC

LIVE

Serial Number

98253403

Owner

Kriya Therapeutics, Inc.

Attorney

Monica Riva Talley

Filing Date

Nov 3, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

KRIYA METABOLIC Trademark

Serial Number: 98253403

KRIYA METABOLIC is a trademark filed by Kriya Therapeutics, Inc. on November 3, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Kriya Therapeutics, Inc. (24 trademarks)

Palo Alto, CA 94306

Entity Type: 03

Legal Representation

Attorney of Record

Monica Riva Talley

2,966 trademarks filed View all →

Correspondence Address

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

1101 K STREET, N.W.

10TH FLOOR

WASHINGTON, DC 20005

United States

Trademark Details

Filing Date

November 3, 2023

Registration Date

Not Registered

Published for Opposition

April 9, 2024

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 30, 2026 EXRA

SOU EXTENSION 4 GRANTED

May 29, 2026 EX4G

SOU EXTENSION 4 FILED

May 29, 2026 EXT4

SOU TEAS EXTENSION RECEIVED

May 29, 2026 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 2, 2025 EXRA

SOU EXTENSION 3 GRANTED

Dec 1, 2025 EX3G

SOU EXTENSION 3 FILED

Dec 1, 2025 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 1, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 1, 2025 EXRA

SOU EXTENSION 2 GRANTED

May 1, 2025 EX2G

SOU EXTENSION 2 FILED

Apr 30, 2025 EXT2

SOU TEAS EXTENSION RECEIVED

Apr 30, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 31, 2024 EXRA

SOU EXTENSION 1 GRANTED

Oct 31, 2024 EX1G

SOU EXTENSION 1 FILED

Oct 31, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Oct 31, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 4, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 9, 2024 NPUB

PUBLISHED FOR OPPOSITION

Apr 9, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 20, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 4, 2024 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 1, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 1, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 1, 2024 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 1, 2024 CNEA

ASSIGNED TO EXAMINER

Mar 1, 2024 DOCK

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 14, 2023 GNRN

NON-FINAL ACTION E-MAILED

Dec 14, 2023 GNRT

NON-FINAL ACTION WRITTEN

Dec 14, 2023 CNRT

ASSIGNED TO EXAMINER

Dec 7, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 21, 2023 NWOS

NEW APPLICATION ENTERED

Nov 7, 2023 NWAP

Related Trademarks

More from this Owner

GENE THERAPY. REDEFINED.

KRIYA NEUROLOGY

KRIYA

More in Same Class

Serial #98253168

SABLUTIN